Logo der Gerresheimer AG
Therapeutic Areas

Ophthalmology

We are thriving for excellence

That’s also why we can proudly announce not just to offer the broadest product portfolio for ophthalmology but also to positioned ourselves as the experts regarding primary packaging in this therapeutic segment in the last years.

Facts and figures

According to WHO, at least 1 billion people suffer from an eye disease

Gerresheimer currently covers around two-third of the demands for pre-fillalbe syringes used for VEGF-A inhibitor treatments

Broadest portfolio in the market – a solution for every specialty

Ophthalmics

Ocular diseases can be various. Some, such as DED (dry eye disease), only affect the ocular surface whilst other common diseases are more related to the retina (e. g. macular degeneration) or even the inside of the eye (e. g. uveitis).

Not just the types of diseases are various but also the treating options. From treating symptoms to enhancing or blocking functionality by injecting proteins to next generation drug technologies to even cure chronic and hereditary diseases (e. g. retinitis pigmentosa).

Whitepaper

New possibilities in terminal sterilization

Facilitating Microliter Dosing for Intravitreal Application

Contact the expert

Dave Long

Global Director Sales & Business Development Syringe Systems

By submitting this form, your inquiry will be forwarded to the responsible contact person within the Gerresheimer Group (which may be located outside the EU/EEA) for processing. Details regarding data transfer and the recipients can be found in our Privacy Policy.